These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 190683)

  • 1. An analog of enkephalin having prolonged opiate-like effects in vivo.
    Walker JM; Berntson GG; Sandman CA; Coy DH; Schally AV; Kastin AJ
    Science; 1977 Apr; 196(4285):85-7. PubMed ID: 190683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesia induced in vivo by central administration of enkephalin in rat.
    Belluzzi JD; Grant N; Garsky V; Sarantakis D; Wise CD; Stein L
    Nature; 1976 Apr; 260(5552):625-6. PubMed ID: 1264229
    [No Abstract]   [Full Text] [Related]  

  • 3. Opiate mechanisms in the central amygdala and gastric stress pathology in rats.
    Ray A; Henke PG; Sullivan RM
    Brain Res; 1988 Feb; 442(1):195-8. PubMed ID: 2834014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical analgesia produced by low doses of the opiate-antagonist naloxone is mediated by interaction at a site with characteristics of the delta opioid receptor.
    Taiwo YO; Basbaum AI; Perry F; Levine JD
    J Pharmacol Exp Ther; 1989 Apr; 249(1):97-100. PubMed ID: 2540325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraventricular Met5-enkephalin causes unexpected lowering of pain threshold and narcotic withdrawal signs in rats.
    Leybin L; Pinsky C; LaBella FS; Havlicek V; Rezek M
    Nature; 1976 Dec; 264(5585):458-9. PubMed ID: 187953
    [No Abstract]   [Full Text] [Related]  

  • 7. Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness.
    Bloom F; Segal D; Ling N; Guillemin R
    Science; 1976 Nov; 194(4265):630-2. PubMed ID: 185694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Ala2,F5Phe4-dynorphin amide, an opiate with analgesic and toxic properties.
    Kostrzewa RM; Brus R; Coy DH; Criswell H; Coogan PS; Kastin AJ
    Pol J Pharmacol Pharm; 1992; 44(2):109-20. PubMed ID: 1357636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epileptic properties of leucine- and methionine-enkephalin: comparison with morphine and reversibility by naloxone.
    Frenk H; Urca G; Liebeskind JC
    Brain Res; 1978 May; 147(2):327-37. PubMed ID: 206315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for analgesic activity of enkephalin in the mouse.
    Buscher HH; Hill RC; Römer D; Cardinaux F; Closse A; Hauser D; Pless J
    Nature; 1976 Jun; 261(5559):423-5. PubMed ID: 934276
    [No Abstract]   [Full Text] [Related]  

  • 12. A morphine-like factor in mammalian brain: analgesic activity in rats.
    Pert A; Simantov R; Snyder SH
    Brain Res; 1977 Nov; 136(3):523-33. PubMed ID: 200309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proabsorptive effect of D-ala2-metenkephalinamide is mediated by naloxone-sensitive opiate receptors in the isolated perfused ileum.
    Bastidas JA; Yeo CJ; Schmieg RE; Zinner MJ
    Surgery; 1990 Jun; 107(6):648-54. PubMed ID: 2162083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enkephalin inhibits firing of myenteric neurones.
    North RA; Williams JT
    Nature; 1976 Dec; 264(5585):460-1. PubMed ID: 187954
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study.
    Bodnar RJ; Williams CL; Lee SJ; Pasternak GW
    Brain Res; 1988 Apr; 447(1):25-34. PubMed ID: 2838129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic.
    Pert CB; Pert A; Chang JK; Fong BT
    Science; 1976 Oct; 194(4262):330-2. PubMed ID: 968485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of dermorphin-induced catalepsy with naloxone, TRH-analog CG3703 and the benzodiazepine antagonist, Ro 15-1788.
    Paakkari P; Feuerstein G
    Neuropharmacology; 1988 Oct; 27(10):1007-12. PubMed ID: 2907115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects of mu antagonists after naloxone non-reversible stress-induced analgesia.
    Sacerdote P; Mantegazza P; Panerai AE
    Brain Res; 1985 Dec; 359(1-2):34-8. PubMed ID: 3000523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory influences of FMRFamide and PLG on stress-induced opioid analgesia and activity.
    Kavaliers M; Hirst M
    Brain Res; 1986 May; 372(2):370-4. PubMed ID: 2871903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.